Latest news
AstraZeneca Expands India Market Access for Enhertu with Additional Breast Cancer Indication - NAVLIN DAILYNAVLIN DAILY · Mon, 10 Aug 2026 09:31:53 GMTParliamentary Panel Urges Greater Public Participation in India’s New Drug Price Fixation - NAVLIN DAILYNAVLIN DAILY · Mon, 10 Aug 2026 08:45:14 GMTIndia Plans New Law to Overhaul Drug Regulations - NAVLIN DAILYNAVLIN DAILY · Fri, 07 Aug 2026 11:07:27 GMTIndian Government Tightens GLP-1 Drug Ad Rules - NAVLIN DAILYNAVLIN DAILY · Fri, 07 Aug 2026 09:39:08 GMTParliamentary Panel Asks DoP to Consider Reintroducing Cost-Based Drug Pricing - NAVLIN DAILYNAVLIN DAILY · Fri, 07 Aug 2026 08:37:17 GMTDelhi HC Seeks Responses in Natco’s Challenge Against Novartis Patent for Cancer Drug Kisqali - NAVLIN DAILYNAVLIN DAILY · Thu, 06 Aug 2026 10:02:30 GMTIndian Panel Seeks DoP Update on Stakeholder Talks Over Non-Scheduled Drug Pricing - NAVLIN DAILYNAVLIN DAILY · Thu, 06 Aug 2026 08:22:03 GMTIndian Pharma Alliance Works with CDSCO to Regularize ‘Legacy’ Drug Approvals - NAVLIN DAILYNAVLIN DAILY · Wed, 05 Aug 2026 12:54:50 GMT